Company Filing History:
5 out of 1,151 
1 out of 247 
1 out of 5 
Years Active: 1999-2018
Title: The Innovative Contributions of Mark A. Ator
Introduction
Mark A. Ator is a notable inventor based in Paoli, Pennsylvania, with a significant portfolio of eight patents. His work primarily focuses on advancements in cancer treatment and enzymatic activity modulation. Ator's innovative contributions have the potential to impact various medical fields significantly.
Latest Patents
Among his latest patents, one notable invention is titled "Methods of treating various cancers using an AXL/cMET inhibitor in combination with other agents." This application describes the use of a specific compound, either alone or in combination with other therapeutically active agents, for treating particular cancers, including solid or hematological cancers where AXL or c-Met is over-expressed. Another significant patent is "Multicyclic compounds and the use thereof," which is directed towards novel multicyclic molecules that mediate enzymatic activity. These compounds may be effective in treating diseases related to the activity of PARP, VEGFR2, and MLK3 enzymes, including neurodegenerative diseases, inflammation, ischemia, and cancer.
Career Highlights
Mark A. Ator has worked with prominent companies in the pharmaceutical industry, including Vertex Pharmaceuticals, Inc. and Cephalon, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field of medicine.
Collaborations
Throughout his career, Ator has collaborated with notable professionals, including Roland Ellwood Dolle and Denton W. Hoyer. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
Mark A. Ator's innovative work in cancer treatment and enzymatic activity modulation showcases his significant contributions to the field of medicine. His patents reflect a commitment to advancing healthcare solutions and improving patient outcomes.